Lymphoma & Hematology Department Home > Departments > MEDICAL ONCOLOGY > Lymphoma & Hematology Department

Introduction

The Department of Lymphoma & Hematology mainly make use of internal medicine treatment to cure tumors. Dr. Yi Pingyong, the chief physician with a doctorate degree in oncology is the department director. Mrs. Yang Xiangdong, an associate chief nurse,is the head nurse. The department has 4 100-leveled laminar airflow rooms, 2 1000-leveled laminar airflow rooms, 1 horizontal laminar airflow bed, and CS-3000plus blood cell separators. There are in the department 3 chief physicians, 3 associate chief physicians, 2 with doctorate degrees and 3 with master's degrees. 

The department can do chemotherapy ( that of regular dose or larger dose, and that of large dose with hematopoietic stem cell support), endocrinotherapy, immunotherapy and hematopoietic stem cell transplantation to treat lymphoma, hematologic neoplasms, lung cancer, breast cancer, intestinal cancer, gastric cancer, esophageal cancer, malignant melanoma, renal cancer, nasopharynx cancer and testicular cancer, etc. The department pioneered in the province in treating malignant solid tumors through peripheral blood stem cell transplantation and bone marrow transplantation. The project is leading in the province and at the advanced level in China, and has earned the provincial medical progress award.

The department has been devoted to biotherapy of tumors and related researches, while committing to enhancing immunity of the patients to tumors and reducing frequency of recurrence of tumors after operation, chemotherapy or radiotherapy. The department developed auto-tumor vaccine to cure colorectal cancer and lung caner and  lymphokine-activated killer cells to cure malignant tumors. The department has undertaken 2 research programs from Hunan Provincial Health Department and 1 research program from Hunan Provincial Science and Technology Department.